Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer

Journal of Experimental and Clinical Cancer Research

Volumn 36, Issue 1, 2017, Pages

  Zhang, Jun ^a,b   Lin, Zhongqiu ^b   Gao, Yali ^a   Yao, Tingting ^b  

^a JINAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cervical cancer; Diagnosis; Long noncoding RNA; MEG3; Methylation; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; MEG3 NON-CODING RNA, HUMAN;

ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MEG3 GENE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UTERINE CERVIX CANCER; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METASTASIS; PROGNOSIS; PROMOTER REGION; SURVIVAL ANALYSIS; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; ROC CURVE; SURVIVAL ANALYSIS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 85008352545     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-016-0472-2     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10-29.
2. SEER Cancer Statistics Review, 1975-2000. National Cancer Institute. 2003. https://seer.cancer.gov/csr/1975-2000/.
3. Cancer Facts and Figures 2012. American Cancer Society, 2012. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/.
4. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629-41.
5. Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY. Human cancer long non-coding RNA transcriptomes. PLoS One. 2011;6:e25915.
6. Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40:6391-400.
7. Calore FL, Lovat F, Garofalo M. Non-coding RNAs and cancer. Int J Mol Sci. 2013;14(8):17085-110.
8. Sun M, Xia R, Jin F, Xu T, Liu Z, De W, Liu X. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumor Biol. 2014;35(2):1065-73.
9. Peng W, Si S, Zhang Q, Li C, Zhao F, Wang F, Yu J, Ma R. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J Exp Clin Cancer Res. 2015;34:79.
10. Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH, Guo RH. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol. 2015;36(6):4851-9.
11. Gao Y, Lu X. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway. Tumour Biol. 2016;37(2):1461-9.
12. Sheng X, Li J, Yang L, Chen Z, Zhao Q, Tan L, Zhou Y, Li J. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep. 2011;32(1):277-85.
13. Zhang J, Yao T, Wang Y, Yu J, Liu Y, Lin Z. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol Ther. 2016;17(1):104-13.
14. Bird A. Perceptions of epigenetics. Nature. 2007;447(7143):396-8.
15. Laird PW. The power and the promise of DNA methylation makers. Nat Rev Cancer. 2003;3(4):253-66.
16. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-28.
17. Augoff K, McCue B, Plow EF, Sossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer. 2012;30(11):5.
18. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab. 2005;90:2179-86.
19. Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, Xie WP, Hou YY. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.
20. Tan J, Yang X, Zhuang L, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007;21(9):1050-63.